Clinical Trial

Allogeneic Skin Grafting

Study Description

Allogeneic Skin Grafting

The primary study objective is to evaluate local response to split-thickness skin grafts from a matched bone marrow donor to chronic GVHD-affected skin in a hematopoietic stem cell transplant patient.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - CelluTome® Epidermal Harvesting System

split-thickness skin grafts from a matched bone marrow donor using the CelluTome® Epidermal Harvesting System

Additional Information

Official Study Title

Allogeneic Skin Grafting in the Treatment of Chronic Cutaneous Graft-versus-host Disease: a Pilot Study

Clinical Trial ID

NCT04015947

ParticipAid ID

epYDVa